Evidence map›Paper›PMID 34929010›Full record

ArticlePloS one2021

Healthcare-associated links in transmission of nontuberculous mycobacteria among people with cystic fibrosis (HALT NTM) study: Rationale and study design.

Jane E Gross, Silvia Caceres, Katie Poch, Nabeeh A Hasan, Rebecca M Davidson, L Elaine Epperson, Ettie Lipner, Charmie Vang, Jennifer R Honda, Matthew Strand and 5 more

3 registry-linked trialsOpen access · goldAbstract readMulticenter Study
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04024423 completednot on this map

Healthcare-associated Links in Transmission of Nontuberculous Mycobacteria Among Patients With Cystic Fibrosis

TypeobservationalSponsorNational Jewish HealthRan2019 to 2023Enrolled100ConditionsCystic Fibrosis, Nontuberculous Mycobacterium InfectionArmsEpidemiologic investigation
NCT05686837 enrolling by invitationnot on this mapstarted 2022, after this paper: background citation

Prospective Healthcare-Associated Links in Transmission of Nontuberculous Mycobacteria Among People With Cystic Fibrosis

TypeobservationalSponsorUniversity of North Carolina, Chapel HillRan2022 to 2027Enrolled100ConditionsCystic Fibrosis, Nontuberculous Mycobacterial Pulmonary Infection
NCT06155747 recruitingnot on this mapstarted 2023, after this paper: background citation

Transmission and Acquisition of Nontuberculous Mycobacteria Outbreak Investigation (TrANsMIt)

TypeobservationalSponsorUniversity of North Carolina, Chapel HillRan2023 to 2036Enrolled100ConditionsNontuberculous Mycobacterial Pulmonary Infection, Outbreak Investigation, Healthcare Associated Infection, Mycobacterium InfectionsArmsEpidemiologic investigation
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Infection control and hospital epidemiology · 2026
    Article
  2. Article
  3. Article
  4. Infection by Clonally RelatedAmerican journal of respiratory and critical care medicine · 2025
    Article
  5. Article
  6. Genomic epidemiology ofERJ open research · 2024
    Article
  7. Review
  8. Prospective evaluation of nontuberculous mycobacteria disease in cystic fibrosis: The design of the PREDICT study.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2024
    Observational
  9. Molecular Epidemiologic Investigation ofAnnals of the American Thoracic Society · 2023
    Article
  10. Observational
  11. HALTing Nontuberculous Mycobacteria in Cystic Fibrosis Centers: Is There Something in the Water?American journal of respiratory and critical care medicine · 2022
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Jane E GrossDepartment of Pediatrics, National Jewish Health, Denver, CO, United States of America.ORCID 0000-0002-5518-8966
Silvia CaceresDepartment of Medicine, National Jewish Health, Denver, CO, United States of America.
Katie PochDepartment of Medicine, National Jewish Health, Denver, CO, United States of America.
Nabeeh A HasanCenter for Genes, Environment and Health, National Jewish Health, Denver, CO, United States of America.
Rebecca M DavidsonCenter for Genes, Environment and Health, National Jewish Health, Denver, CO, United States of America.
L Elaine EppersonCenter for Genes, Environment and Health, National Jewish Health, Denver, CO, United States of America.
Ettie LipnerCenter for Genes, Environment and Health, National Jewish Health, Denver, CO, United States of America.
Charmie VangCenter for Genes, Environment and Health, National Jewish Health, Denver, CO, United States of America.ORCID 0000-0001-5724-0265
Jennifer R HondaCenter for Genes, Environment and Health, National Jewish Health, Denver, CO, United States of America.
Matthew StrandDivision of Biostatistics, National Jewish Health, Denver, CO, United States of America.
Michael StrongCenter for Genes, Environment and Health, National Jewish Health, Denver, CO, United States of America.
Lisa SaimanDepartment of Pediatrics, Columbia University Irving Medical Center, New York, NY, United States of America.
D Rebecca PrevotsLaboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, United States of America.
Kenneth N OlivierPulmonary Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD, United States of America.
Jerry A NickDepartment of Medicine, National Jewish Health, Denver, CO, United States of America.
National Jewish Health · USColumbia University Irving Medical Center · USNational Heart Lung and Blood Institute · USNational Institute of Allergy and Infectious Diseases · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHealthcare-associated transmission of nontuberculous mycobacteria (NTM) among people with cystic fibrosis (pwCF) has been reported and is of increasing concern. No standardized epidemiologic investigation tool has been published for healthcare-associated NTM outbreak investigations. This report describes the design of an ongoing observational study to standardize the approach to NTM outbreak investigation among pwCF.

methodsThis is a parallel multi-site study of pwCF within a single Center who have respiratory NTM isolates identified as being highly-similar. Participants have a history of positive airway cultures for NTM, receive care within a single Center, and have been identified as part of a possible outbreak based on genomic analysis of NTM isolates. Participants are enrolled in the study over a 3-year period. Primary endpoints are identification of a shared healthcare-associated encounter(s) among patients in a Center and identification of environmental isolates that are genetically highly-similar to respiratory isolates recovered from pwCF. Secondary endpoints include characterization of potential transmission modes and settings, as well as incidence and prevalence of healthcare-associated environmental NTM species/subspecies by geographical region. DISCUSSION: We hypothesize that genetically highly-similar strains of NTM among pwCF cared for at the same Center may arise from healthcare sources including patient-to-patient transmission and/or acquisition from environmental sources. This novel study design will establish a standardized, evidence-based epidemiologic investigation tool for healthcare-associated NTM outbreak investigation within CF Care Centers, will broaden the scope of independent outbreak investigations and demonstrate the frequency and nature of healthcare-associated NTM transmission in CF Care Centers nationwide. Furthermore, it will provide valuable insights into modeling risk factors associated with healthcare-associated NTM transmission and better inform future infection prevention and control guidelines. This study will systematically characterize clinically-relevant NTM isolates of CF healthcare environmental dust and water biofilms and set the stage to describe the most common environmental sources within the healthcare setting harboring clinically-relevant NTM isolates.

trial registrationClinicalTrials.gov NCT04024423. Date of registry July 18, 2019.

Indexed as

Nontuberculous MycobacteriaCross InfectionCystic FibrosisFemaleHumansMaleMycobacterium Infections, NontuberculousRisk Factors

Identifiers

PMID34929010
PMCPMC8687591
OpenAlexW4200311588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.